Compare CLRO & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLRO | VVOS |
|---|---|---|
| Founded | 1983 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4M | 15.1M |
| IPO Year | 2018 | 2020 |
| Metric | CLRO | VVOS |
|---|---|---|
| Price | $4.27 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 6.0K | ★ 95.5K |
| Earning Date | 03-10-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,067,000.00 | $15,031,000.00 |
| Revenue This Year | N/A | $31.42 |
| Revenue Next Year | N/A | $49.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 11.59 | 8.91 |
| 52 Week Low | $0.29 | $1.19 |
| 52 Week High | $15.42 | $7.40 |
| Indicator | CLRO | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 43.99 |
| Support Level | $4.15 | N/A |
| Resistance Level | $4.53 | $1.50 |
| Average True Range (ATR) | 0.41 | 0.12 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 9.17 | 58.06 |
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.